دورية أكاديمية

High level of serum complement 3 is a risk factor for vascular stenosis progression in TA patients receiving tocilizumab: a prospective observational study

التفاصيل البيبلوغرافية
العنوان: High level of serum complement 3 is a risk factor for vascular stenosis progression in TA patients receiving tocilizumab: a prospective observational study
المؤلفون: Rongyi, ChenAff1, Aff2, Xiaojuan, DaiAff1, Aff2, Jinghua, WangAff1, Aff2, Lingying, MaAff1, Aff2, Xiaomin, DaiAff1, Aff2, Lili, MaAff1, Aff2, Huiyong, ChenAff1, Aff2, IDs13075023031067_cor7, Lindi, JiangAff1, Aff2, IDs13075023031067_cor8, Ying, SunAff1, Aff2, IDs13075023031067_cor9
المصدر: Arthritis Research & Therapy. 25(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:14786362
DOI:10.1186/s13075-023-03106-7